A new approach to assessing sweat production

Since 1916 when Stillians (1) first reported that excessive axillary sweating could be reduced by the application of 25% aqueous aluminium chloride, sales of antiperspirant products have increased dramatically. In spite of many studies, the mechanism of action of these compounds has not been clearly elucidated (2). In most cases, investigations have been performed on animal foot pads, excised human biopsy specimens and skin samples in vivo (3). A model which eliminated problems encountered in whole body investigations (for example, influence of blood flow) would be preferable. One such method, introduced in part by Sato (3), has been investigated. Preliminary investigations suggest that this method could become useful in the evaluation of the mode of action of antiperspirants.
Sweat production was induced using carbachol and methacholine in isolated rat plantar sweat glands. These were maintained in a suitable environment (modified Krebs-Ringer bicarbonate at 38°C containing 30% w/v fresh rat serum). The output of sweat was measured every 5 minutes for 85 minutes and the maximal final volume obtained with any one gland was 23 nanolitres.
Sweat production ceased on administration of appropriate concentrations of atropine or the withdrawal of calcium ions from the bathing fluid.
Une nouvelle approche pour évaluer la transpiration     

The evaluation of underarm deodorants

Double-blind cross-over trials in which trained assessors evaluated axillary malodour on a 0 to 10 scale showed that ethanol at 60% and 99% w/w significantly reduced odour for up to 24 h. Reduction in odour was increased by the addition of non-volatile antimicrobial ingredients such as chlorhexidine, Irgasan DP 300 (Triclosan, Ciba Geigy) or aluminium chlorhydrate.
Volunteer panellists were able to identify statistically significant deodorant effects when they rated their own axillary odour on a 0 to 10 scale.
An odour absorber, zinc ricinoleate (Grillocin, Grillo-Werke, A. G.) was used to treat existing malodour and gave reduced perception of that malodour for up to 24 h.
A close correlation was found between panel odour scores and the bacterial status of the axilla as assessed by the replipad technique when biocidal systems were studied. Irgasan DP 300, a bacteriostat, did not perform so well in skin flora sampling procedures, but was nevertheless effective as a deodorant ingredient. Thus in vivo microbiological techniques, although often useful as predictors of deodorancy, do not replace the carefully controlled clinical trial with direct assessment of odour.
L'evaluation de l'odeur des aisselles     

共轭亚油酸对乳腺脂类代谢和乳腺发育的作用及其机理

共轭亚油酸(Conjugated Linoleic Acid,CLA)是亚油酸具有共轭双键的一组同分异构体,由瘤胃细菌在生物氢化过程中合成,具有抗癌、抗炎症、抗动脉粥样硬化等多种生物学功能。CLA在代谢方面也有调节作用,能影响全身代谢,影响肝脏、乳腺以及富含脂肪的相关组织代谢。在此介绍了CLA的来源、结构、对动物乳腺脂类代谢和乳腺发育的作用及其机理。     

小鼠乳腺中FGF7及其受体的表达与作用

为了从蛋白水平研究成纤维细胞生长因子7（FGF7）及其受体（KGFR）在哺乳动物乳腺发育、泌乳及退化过程中表达定位的动态变化,揭示FGF7及其受体表达变化与乳腺发育及泌乳功能的关系,本研究利用激光扫描共聚焦显微系统对昆明鼠乳腺中FGF7及其受体的表达进行了免疫荧光检测,利用体外培养不同发育时期的小鼠乳腺组织研究了FGF7在乳腺中的作用。结果表明：FGF7主要定位于乳腺导管上皮细胞以及腺泡上皮细胞外周,同时在基质中有弱的表达。KGFR主要出现在导管上皮细胞以及腺泡上皮细胞上,在乳腺发育的个别时期细胞外基质中有弱表达。FGF7在退化4d达到最高值;KGFR在泌乳4d达到最高值。除青春期和妊娠期外,添加FGF7均能显著诱导乳腺上皮细胞产生KGFR。FGF7能促进小鼠乳腺上皮细胞的增殖分化,降低乳腺上皮细胞的细胞凋亡。     

Drugs – Do we need them? Applications of non-pharmaceutical therapy in anterior eye disease: A review

Natural products have been in use long before the introduction of modern drug therapies and are still used in various communities worldwide for the treatment of anterior eye disease. The aim of this review is to look at the current non-pharmaceutical modalities that have been tried and assess the body of existing evidence behind them. This includes alternative medicine, existing non-pharmaceutical therapy and more recent low and high tech solutions.A detailed search of all available databases including MEDLINE, Pubmed and Google was made to look for English-language studies for complementary and alternative treatment modalities (CAM), natural therapies and new modalities for anterior eye disease such as blepharitis, dry eye and microbial keratitis. We have included a broad discussion ranging from traditional treatments like honey and aloe vera which have been used for centuries, to the more recent technological advances like Intense Pulsed Light (IPL), LipiFlow and photoactivated chromophore for corneal cross linking in infectious keratitis (PACK-CXL).Alternative management strategies may have a role in anterior eye diseases and have a potential in changing the way we currently approach them. Some of the available CAM could play a role if incorporated in to current management practices of not only chronic diseases like blepharitis and dry eye, but also acute conditions with significant morbidity like microbial keratitis. Further large-scale randomized control trials stratified by disease severity are required to improve our understanding and to evaluate the use of non-pharmaceutical therapy against current practice.     

Short communication: relationship between body growth and mammary development in dairy heifers

Our objective was to determine if prepubertal rate of body weight (BW) gain, independent of diet, was related to mammary development of dairy heifers. Data from two studies recently conducted at Michigan State University were used to identify factors, within a dietary treatment group, that would account for variation in first lactation milk production or amount of mammary parenchymal DNA at the time of puberty. Factors analyzed for variation in milk production during first lactation were: postpartum BW, prepubertal BW gain, gestational BW gain, postpartum BW gain, body condition score (BCS) at breeding, and BCS at calving. Factors analyzed for variation in mammary parenchymal DNA at puberty were: BW at slaughter, age at puberty, prepubertal BW gain and body protein and body fat content at slaughter. For both analyses, prepubertal BW gain did not account for any of the variation in mammary development. The only significant covariate for the milk production model (r2 = 0.44) was BCS at breeding. Similarly, the only significant covariate in the parenchymal DNA model (r2 = 0.22) was body fat content at slaughter. These results suggest that, within a dietary treatment, heifers that grow faster do not have impaired mammary development, and increased body fatness may be a better predictor of impaired mammary development than BW gain.     

IGFBP-5在乳腺发育过程中的生物学作用

细胞生长的调节主要由IGFs起作用,IGFBPs能够通过蛋白水解、翻译后修饰以及同细胞表面和细胞外基质的相互作用来加强或抑制IGFs的作用,从而调节细胞的增殖、存活和分化.IGFBPs也具有独立的作用方式.IGFBP-5与乳腺发育特别是乳腺退化关系密切,IGFBP-5的表达可能是细胞凋亡发生时的普遍事件,尤其是在乳腺退化的初始阶段.